Intressa Vascular

Intressa Vascular is a Belgian clinical-stage medical device company focused on innovative endovascular treatments for aortic dissection, a serious cardiovascular condition. The company is developing the Allay® Aortic Stent, a multilayer stent designed to treat Type B aortic dissections and residual dissections. This stent aims to recentralize blood flow within the true lumen of the aorta while preserving branch perfusion, enhancing patient outcomes with a streamlined procedure and low complication risk. The Allay® Aortic Stent utilizes proprietary multilayer braiding technology and personalized procedure planning to meet the clinical needs of aortic dissection, which affects around 200,000 new patients each year in major markets like the EU, USA, China, and Japan. Intressa Vascular's team consists of over 30 professionals with expertise in life sciences, healthcare, engineering, and business, all dedicated to advancing patient care through innovation. The company is led by CEO Pierre Douette and a team of key executives guiding its strategic and clinical development efforts.

• Employees 23
• Total Funding $17741106